Prof Research published a new market report on Low Dead Space Syringe Market. It presents the largest 10 manufacturers in Low Dead Space Syringe Market. The report is a professional and in-depth study of the current state of the global Low Dead Space Syringe market. The report provides key statistics on the market of Low Dead Space Syringe. It is a valuable source of guidance and direction for companies and individuals interested in the Low Dead Space Syringe industry.

A low dead space syringe is a type of syringe that has been designed to reduce the amount of dead space in the needle hub and plunger. Dead space is the space between the needle hub and the plunger of the syringe that is not occupied by the medication being administered. When using a syringe with a high dead space, a small amount of medication can remain trapped in the dead space after injection, leading to medication waste and potential dosing errors.

Low dead space syringes are commonly used for administering vaccines, insulin, and other medications where accurate dosing is critical. They are also used in situations where there is a shortage of medication, as they help to minimize waste.

The global Low Dead Space Syringe market was valued at 167.47 million USD in 2022. The Low Dead Space Syringe production value is anticipated to have growth with a CAGR of -0.14% in the coming years to reach 166.04 million USD in 2028.

The market is dominated by major players such as Retractable Technologies, BD, Cardinal Health, Terumo, ICU Medical, B Braun, Sol-Millennium, Vernacare, Nipro, and UltiMed. These companies are investing heavily in research and development to develop new and innovative low dead space syringes to meet the growing demand from the healthcare industry.

Retractable Technologies is the world's largest manufacturer of Low Dead Space Syringe, and it has a market share of 43.6% in value. Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare industry. Its products are marketed under the VanishPoint, Patient Safe, and EasyPoint brands. The company has four segments: Syringes, Blood Collection Products, FasyPoint® Needles, and Other Products.

ICU Medical is the world's second-largest manufacturer of Low Dead Space Syringe, and it has a market share of 14.5% in value. ICU Medical, Inc. (ICU) is engaged in the development, manufacturing and sale of medical products used in infusion therapy and critical care applications. ICU Medical completes the acquisition of Smiths Medical in 2022. ICU Medical has four segmnets: John Crane, Smiths Detection, Flex-Tek, and Smiths Interconnect.

Vernacare is the world's third largest manufacturer of Low Dead Space Syringe, and it has a market share of 8.6% in value. Vernacare is a pioneer of sustainable infection prevention solutions in healthcare environments. They develop, source, manufacture and distribute healthcare products to over 60 countries from our UK manufacturing sites in Bolton, Chorley, South Wales and Works

BD is the world's fourth largest manufacturer of Low Dead Space Syringe, and it has a market share of 7.8% in value. Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others. The company's organizational structure is based upon three principal business segments: BD Medical, BD Life Sciences and BD Interventional.